S'abonner

Seroprevalence and risk factors predicting Toxoplasma gondii (Toxoplasmosis) infection in pregnant women in Koula-Moutou and surrounding departments in central-eastern Gabon - 01/10/22

Doi : 10.1016/j.jemep.2022.100841 
T. Ndong Mba a, c, , A. Mongo Delis b, H. Moudounga Kenguele a, A.B. Pambo-Pambo d, A. Ibouanga Bitegue e, C. Sima Obiang c, P. Mickala a, d
a Laboratory of Molecular, Cellular Biology (LABMC) Masuku University of Science, Technology (USTM), Franceville, Gabon 
b Koula-Moutou Ambulatory Treatment Centre, Koula-Moutou, Gabon 
c Biochemistry Research Laboratory (LAREBIO), University of Science, Technology of Masuku (USTM), Franceville, Gabon 
d Laboratory of Animal Physiology, University of Science, Technology of Masuku (USTM), Franceville, Gabon 
e Paul MOUKAMBI Regional Hospital (CHRPM) of Koula-Moutou, Gabon 

*Corresponding author. Laboratory of Molecular and Cellular Biology (LABMC), Research Laboratory in Biochemistry (LAREBIO) University of Sciences and Techniques of Masuku (USTM), Franceville, Gabon.Laboratory of Molecular and Cellular Biology (LABMC), Research Laboratory in Biochemistry (LAREBIO) University of Sciences and Techniques of Masuku (USTM)FrancevilleGabon

Summary

Background

Serological screening for toxoplasmosis in pregnant women in Gabon is not always systematic during pregnancy. However, whether in urban, rural or semi-rural areas, hygiene and living conditions are often precarious for these populations at risk. This state of affairs constitutes a favorable terrain for the dissemination of the disease. It is in this context that the objective of this study was to investigate the prevalence and risk factors predicting Toxoplama gondii infection in pregnant women in the province of Ogooué-Lolo, of which Koula-Moutou is the capital, a semi-rural area in central-eastern Gabon.

Methods

This prospective, cross-sectional study was conducted from January 2 to February 28, 2022 in a population of pregnant women from two of the most frequented health centers in the commune of Koula-Moutou: the Centre Hospitalier Régional Paul MOUKAMBI (CHRPM) and the Centre de Santé Urbain (CSU) of Koula-Moutou, in east-central Gabon. From serum/plasma collected from pregnant women, the rapid diagnostic immunological technique “Onsite Rapid Test TOXO IgG/IgM Combo”, a lateral flow chromatography immunological test for the simultaneous detection and differentiation of anti-Toxoplasma gondii (T. gondii) IgG and IgM, was used to perform toxoplasma serologies. A pre-established and structured questionnaire on sociodemographic factors and risk factors associated with toxoplasmosis was submitted to the participants and the data obtained were analyzed using R software version 3.6.1.

Results

The study included 97 pregnant women from the city of Koula-Moutou and surrounding departments, aged 16 to 43 years, with a mean age of 27.9±7.1 years. IgG antibodies to Toxoplasma gondii were found in 78 pregnant women, representing a seroprevalence of 80.41% (n=78), among whom 5.13% (n=4) were diagnosed as seropositive to IgM anti-Toxoplasma gondii in this study. In univariate analysis, pupils/students (COR=14.65; 95% CI: [1.86–115.24]), women with a small trade (COR=0.53; 95% CI: [0.12–2.28]), or even those with no professional status (COR=0.19; 95% CI: [0.05–0.74]), those with primary (COR=0.28; 95% CI: [0.09–0.83]), secondary (COR=6.15; 95% CI: [2.1–18.04]) and university (COR=.2; 95% CI: [0.04–0.89]) education, those who were single (COR=3.21; 95% CI: [0. 98–10.55]) and finally, those with a number of pregnancies ranging from 1 to 5 (OR=4.11; 95% CI: [1.41–11.99]), were at high risk of Toxoplasmosis, After adjustment of risk factors by multivariate logistic regression, cohabitation with cats and/or dogs, rabbits, mice (Adjusted OR=0.17; 95% CI: [0.00–0.67]) was identified as the only significant risk factor for Toxoplasmosis (P=0.037) in our study population.

Conclusion

In order to prevent Toxoplasma gondii infections and protect newborns in Gabon, awareness of the risks of contamination, systematic serological surveillance and hygiene measures are necessary and should be proposed to pregnant women during prenatal consultations.

Le texte complet de cet article est disponible en PDF.

Keywords : Gabon, Koula-Moutou, Pregnant women, Risk factors, Seroprevalence, Toxoplasma gondii


Plan


© 2022  Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 24

Article 100841- octobre 2022 Retour au numéro
Article précédent Article précédent
  • Does experience affect physicians’ attitude towards assisted suicide? A snapshot of Swedish doctors’ opinions
  • U. Sandvik, K. Arthur, E. Dahlman, C. Ilonson, N. Olsson, J. Skoog, B. von Zur-Mühlen, T. Mossberg
| Article suivant Article suivant
  • The role of Participatory Action Research in developing new models of healthcare: Perspectives from participants and recommendations for ethical review and governance oversight
  • C. Fogg, E. Lanning, J. Shoebridge, J. Longstaff, R. De Vos, K. Dawson-Taylor, A. Glanville-Hearson, D. Carpenter, S. Court, T. Brown, E. Heiden, A. Chauhan

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.